CD30 targeting with brentuximab vedotin: A novel therapeutic approach to primary effusion lymphoma

Shruti Bhatt, Brittany M. Ashlock, Yasodha Natkunam, Victoria Sujoy, Jennifer Rose Chapman, Juan Carlos Ramos, Enrique A. Mesri, Izidore S. Lossos

Research output: Contribution to journalArticlepeer-review

55 Scopus citations

Fingerprint Dive into the research topics of 'CD30 targeting with brentuximab vedotin: A novel therapeutic approach to primary effusion lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds